​

Agilon Health (AGL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AGL Stock Forecast

Agilon Health (AGL) stock forecast, based on 25 Wall Street analysts, predicts a 12-month average price target of $104.00, with a high of $146.00 and a low of $48.00. This represents a 14.29% increase from the last price of $91.00.

- $30 $60 $90 $120 $150 High: $146 Avg: $104 Low: $48 Last Closed Price: $91

AGL Stock Rating

Agilon Health stock's rating consensus is Hold, based on 25 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (36.00%), 14 Hold (56.00%), 2 Sell (8.00%), and 0 Strong Sell (0.00%).

Hold
Total 25 0 2 14 9 Strong Sell Sell Hold Buy Strong Buy

AGL Price Target Upside V Benchmarks

TypeNameUpside
StockAgilon Health14.29%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks13.55%

Price Target Trends

1M3M12M
# Anlaysts-613
Avg Price Target-$122.50$90.38
Last Closing Price$91.00$91.00$91.00
Upside/Downside-34.62%-0.68%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26-59-115
Sep, 26-411-116
Aug, 26-4101217
Jul, 26-411-217
Jun, 26-411-217
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 15, 2026Bernstein$125.00$92.3835.31%37.36%
Aug 11, 2026Stephen BaxterWells Fargo$146.00$96.7850.86%60.44%
Aug 06, 2026Michael HaRobert W. Baird$116.00$89.5329.57%27.47%
Aug 06, 2026Jailendra SinghTruist Financial$112.00$95.1217.75%23.08%
Aug 06, 2026Barclays$111.00$107.852.92%21.98%
Jul 13, 2026Wells Fargo$141.00$114.8522.77%54.95%
May 26, 2026Andrew MokBarclays$81.00$88.07-8.03%-10.99%
May 08, 2026Wells Fargo$72.00$60.6618.69%-20.88%
May 07, 2026Jack SlevinJefferies$48.00$27.8572.35%-47.25%
May 07, 2026Deutsche Bank$49.00$27.8575.94%-46.15%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 15, 2026BernsteinOutperformupgrade
Aug 11, 2026Wells FargoOverweightOverweighthold
Aug 10, 2026CitigroupSellNeutralupgrade
Aug 06, 2026BenchmarkBuyBuyhold
Jul 23, 2026CitigroupNeutralSelldowngrade
Jul 13, 2026Wells FargoOverweightOverweighthold
May 21, 2026BenchmarkBuyBuyhold
May 15, 2026CitigroupNeutralNeutralhold
May 11, 2026Cowen & Co.HoldHoldhold
May 08, 2026Wells FargoOverweightOverweighthold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.09$-0.26$-0.64$-0.63$-0.98---
Avg Forecast$-1.02$-0.21$-0.34$-0.56$-0.34$-0.21$-0.08$0.06
High Forecast$-0.99$-0.20$-0.20$-0.55$-0.17$-0.07$0.09$0.07
Low Forecast$-1.06$-0.24$-0.39$-0.58$-0.46$-0.34$-0.16$0.06
Surprise %6.86%23.81%88.24%12.50%188.24%---

Revenue Forecast

$0 $3B $6B $9B $12B $15B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.52B$2.39B$4.32B$6.06B$5.93B---
Avg Forecast$1.82B$2.68B$4.50B$6.06B$6.61B$7.52B$8.82B$10.74B
High Forecast$1.88B$2.96B$4.52B$6.07B$7.44B$7.58B$10.15B$12.36B
Low Forecast$1.78B$2.56B$4.48B$6.03B$6.11B$7.45B$8.26B$10.06B
Surprise %-16.56%-10.97%-4.16%0.06%-10.20%---

Net Income Forecast

$-450M $-350M $-250M $-150M $-50M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-406.49M$-106.55M$-262.60M$-260.15M$-391.35M---
Avg Forecast$-417.34M$-85.51M$-120.91M$-230.95M$-167.88M$-100.54M$-38.35M$24.54M
High Forecast$-404.50M$-80.44M$-83.25M$-223.62M$-70.36M$-28.36M$36.25M$29.36M
Low Forecast$-433.14M$-96.84M$-158.57M$-238.28M$-189.98M$-138.23M$-65.25M$22.52M
Surprise %-2.60%24.61%117.18%12.65%133.12%---

AGL Forecast FAQ

Is Agilon Health stock a buy?

Agilon Health stock has a consensus rating of Hold, based on 25 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 14 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Agilon Health is a neutral investment for most analysts.

What is Agilon Health's price target?

Agilon Health's price target, set by 25 Wall Street analysts, averages $104 over the next 12 months. The price target range spans from $48 at the low end to $146 at the high end, suggesting a potential 14.29% change from the previous closing price of $91.

How does Agilon Health stock forecast compare to its benchmarks?

Agilon Health's stock forecast shows a 14.29% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (13.55%).

What is the breakdown of analyst ratings for Agilon Health over the past three months?

  • October 2026: 0% Strong Buy, 33.33% Buy, 60.00% Hold, 0% Sell, 6.67% Strong Sell.
  • September 2026: 0% Strong Buy, 25.00% Buy, 68.75% Hold, 0% Sell, 6.25% Strong Sell.
  • August 2026: 0% Strong Buy, 23.53% Buy, 58.82% Hold, 5.88% Sell, 11.76% Strong Sell.

What is Agilon Health’s EPS forecast?

Agilon Health's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.21, marking a -78.57% decrease from the reported $-0.98 in 2025. Estimates for the following years are $-0.08 in 2027, and $0.06 in 2028.

What is Agilon Health’s revenue forecast?

Agilon Health's average annual revenue forecast for its fiscal year ending in December 2026 is $7.52B, reflecting a 26.70% increase from the reported $5.93B in 2025. The forecast for 2027 is $8.82B, and $10.74B for 2028.

What is Agilon Health’s net income forecast?

Agilon Health's net income forecast for the fiscal year ending in December 2026 stands at $-101M, representing a -74.31% decrease from the reported $-391M in 2025. Projections indicate $-38.35M in 2027, and $24.54M in 2028.